Personalized mRNA cancer vaccine therapy is a therapy that uses a personalized cancer vaccine based on mRNA vaccine technology to target existing tumors in patients. As of 2024[update], number of mRNA cancer vaccines are in clinical trials, of which many are personalized therapies based on engineering mRNA-mediated immune response that targets the patient's particular strain of cancer cells.[1]
Experimental treatments include treatments for pancreatic cancer, head and neck cancers, and melanoma.[2][3][4]
In 2024, the British National Health Service announced that had launched its Cancer Vaccine Launch Pad, a collaboration for trials for the use of personalized mRNA cancer vaccines on its patients.[5]
References
edit- ^ Yao, Ruhui; Xie, Chunyuan; Xia, Xiaojun (2024-12-31). "Recent progress in mRNA cancer vaccines". Human Vaccines & Immunotherapeutics. 20 (1). doi:10.1080/21645515.2024.2307187. ISSN 2164-5515. PMC 10826636. PMID 38282471.
- ^ Kang, Ning; Zhang, Si; Wang, Yuzhuo (2023). "A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer". Holistic Integrative Oncology. 2 (1): 18. doi:10.1007/s44178-023-00042-z. ISSN 2731-4529. PMC 10248956. PMID 37323470.
- ^ Shibata, Hirofumi; Zhou, Liye; Xu, Na; Egloff, Ann Marie; Uppaluri, Ravindra (March 2021). "Personalized cancer vaccination in head and neck cancer". Cancer Science. 112 (3): 978–988. doi:10.1111/cas.14784. ISSN 1349-7006. PMC 7935792. PMID 33368875.
- ^ Carvalho, Thiago (2023-08-16). "Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial". Nature Medicine. 29 (10): 2379–2380. doi:10.1038/d41591-023-00072-0. PMID 37773210.
- ^ Walsh, Fergus (2024-05-30). "Thousands to trial personalised cancer vaccines". BBC News. Retrieved 2024-06-01.
External links
edit
 | This oncology article is a stub. You can help Wikipedia by expanding it. |
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |